DE2449927C2 - Neue stabile polymorphe kristalline Form von 1-Hydroxy-3-(1',1'-dimethylheptyl)-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-on und diese polymorphe Form enthaltende pharmazeutische Zubereitung - Google Patents
Neue stabile polymorphe kristalline Form von 1-Hydroxy-3-(1',1'-dimethylheptyl)-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-on und diese polymorphe Form enthaltende pharmazeutische ZubereitungInfo
- Publication number
- DE2449927C2 DE2449927C2 DE2449927A DE2449927A DE2449927C2 DE 2449927 C2 DE2449927 C2 DE 2449927C2 DE 2449927 A DE2449927 A DE 2449927A DE 2449927 A DE2449927 A DE 2449927A DE 2449927 C2 DE2449927 C2 DE 2449927C2
- Authority
- DE
- Germany
- Prior art keywords
- polymorphic
- dibenzo
- hexahydro
- pyran
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41301173A | 1973-11-05 | 1973-11-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2449927A1 DE2449927A1 (de) | 1975-05-07 |
| DE2449927C2 true DE2449927C2 (de) | 1985-07-04 |
Family
ID=23635422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2449927A Expired DE2449927C2 (de) | 1973-11-05 | 1974-10-21 | Neue stabile polymorphe kristalline Form von 1-Hydroxy-3-(1',1'-dimethylheptyl)-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-on und diese polymorphe Form enthaltende pharmazeutische Zubereitung |
Country Status (24)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4278603A (en) * | 1973-11-05 | 1981-07-14 | Eli Lilly And Company | Novel polymorphic crystalline form of dibenzopyranone |
| US4195078A (en) * | 1979-03-09 | 1980-03-25 | Eli Lilly And Company | Nabilone granulation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3507885A (en) * | 1966-03-25 | 1970-04-21 | Hoffmann La Roche | 3-alkyl-6h-dibenzo(b,d)pyrans |
-
1974
- 1974-09-20 IE IE1949/74A patent/IE39678B1/xx unknown
- 1974-09-23 ZA ZA00746029A patent/ZA746029B/xx unknown
- 1974-09-25 NL NL7412682A patent/NL7412682A/xx not_active Application Discontinuation
- 1974-09-27 IL IL45742A patent/IL45742A/xx unknown
- 1974-09-27 PH PH16343A patent/PH11719A/en unknown
- 1974-10-01 CA CA210,510A patent/CA1028715A/en not_active Expired
- 1974-10-05 ES ES431672A patent/ES431672A1/es not_active Expired
- 1974-10-14 SE SE7412921A patent/SE407062B/xx unknown
- 1974-10-17 SU SU742069769A patent/SU611591A3/ru active
- 1974-10-21 DE DE2449927A patent/DE2449927C2/de not_active Expired
- 1974-10-24 AT AT856674A patent/AT335453B/de not_active IP Right Cessation
- 1974-10-28 YU YU02878/74A patent/YU287874A/xx unknown
- 1974-10-31 FR FR7436368A patent/FR2249665B1/fr not_active Expired
- 1974-10-31 PL PL1974175276A patent/PL94119B1/pl unknown
- 1974-10-31 BE BE150088A patent/BE821720A/xx not_active IP Right Cessation
- 1974-11-04 GB GB47516/74A patent/GB1487635A/en not_active Expired
- 1974-11-04 DD DD182141A patent/DD115660A5/xx unknown
- 1974-11-04 CS CS7516A patent/CS174793B2/cs unknown
- 1974-11-04 DK DK573374AA patent/DK136720B/da not_active IP Right Cessation
- 1974-11-04 HU HUEI574A patent/HU167751B/hu unknown
- 1974-11-05 BG BG028123A patent/BG27088A3/xx unknown
- 1974-11-05 JP JP49127923A patent/JPS5943463B2/ja not_active Expired
- 1974-11-05 AR AR256414A patent/AR202670A1/es active
- 1974-11-05 RO RO7480429A patent/RO71769A/ro unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3786316T2 (de) | Überzugsmembran und damit hergestellte Mittel. | |
| DE69322087T2 (de) | Neues kristall von heterozyclischen bis(phosphonsäure) monohydrat-derivat | |
| DE3886075T2 (de) | Verwendung von Metformin zur Herstellung von Arzneimitteln. | |
| EP0078820A4 (de) | Inklusionscomplexe von n-(1-phenyläthyl)-3,3-diphenylpropylamin bzw. dessen hydrochlorid mit cyclodextrin, verfahren zur herstellung dieser inklusionskomplexe sowie diese inklusionskomplexe enthaltende pharmazeutische präparate. | |
| DE2721171A1 (de) | Neues vincaminsalz, seine herstellung und es enthaltende pharmazeutische zubereitungen | |
| CH647534A5 (de) | Cyclodextrin-kamillen-inklusionskomplexe, verfahren zur herstellung der komplexe und die komplexe enthaltenden praeparate. | |
| DE2952114C2 (de) | Verwendung von Rosmarinsäure bei der Bekämpfung von Entzündungen und hierbei eingesetzte Arzneimittel | |
| DD208613A5 (de) | Verfahren zur herstellung neuer kristallmodifikationen des (+)-catechinmonohydrats und des (+)-catechinanhydrats | |
| DE68915269T2 (de) | Polyvalentes entzündungshemmendes mittel. | |
| DE2449927C2 (de) | Neue stabile polymorphe kristalline Form von 1-Hydroxy-3-(1',1'-dimethylheptyl)-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-on und diese polymorphe Form enthaltende pharmazeutische Zubereitung | |
| DE1670005C2 (de) | β-(4,5-Diphenyloxazol-2-yl)-propionsäure oder ein pharmazeutisch verträgliches Salz davon, Verfahren zur Herstellung dieser Verbindungen und pharmazeutische Zubereitungen, welche diese Verbindungen enthalten | |
| DE3443065A1 (de) | Kristallines cephalexinhydrochloridmonohydrat, verfahren zu seiner herstellung und seine verwendung | |
| CH647677A5 (de) | 4'-(acridinylamino)-methansulfon-anisidid enthaltende pharmazeutische zusammensetzung. | |
| DE3051068C2 (enrdf_load_stackoverflow) | ||
| DE2451933C2 (enrdf_load_stackoverflow) | ||
| DE2510663B2 (de) | Aluminiumpolyhydroxisulfat sowie dieses enthaltendes Arzneimittel | |
| AT329556B (de) | Verfahren zur herstellung einer neuen stabilen polymorphen kristallinen form von 1-hydroxy-3-(1',1'-dimethylheptyl)-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9h-dibenzo(b,d)pyran-9-on | |
| DE2417993A1 (de) | Megluminkomplexe antimykotischer polyenantibiotika, der makrolide, verfahren zu ihrer herstellung und arzneimittel auf der basis dieser stoffe | |
| DE2724608C2 (de) | 1-(4-Isopropylthiophenyl)-2-n-octylaminopropanol enthaltende pharmazeutische Zubereitung | |
| EP0054215A1 (de) | (8-(Dialkylaminoalkoxy)-coffein)-Platinkomplexe, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
| EP3820524B1 (de) | Hypericin-pvp komplex mit hohem hypericinanteil | |
| DE2901914A1 (de) | Neues derivat der n-acetyl-amino-6- capronsaeure, verfahren zu dessen herstellung und arzneimittel unter verwendung des derivats als wirkstoff | |
| DE2501649A1 (de) | Thiophen-carbonsaeuresalze des papaverins, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel | |
| DE1493245C (de) | Überzugsmittel für orale magensaftloshche Arzneimittel | |
| DE2746087A1 (de) | Cyclodextrin-einschlusskomplexe mit indomethacin, verfahren zu ihrer herstellung und pharmazeutische mittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8128 | New person/name/address of the agent |
Representative=s name: SPOTT, G., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 800 |
|
| D2 | Grant after examination | ||
| 8330 | Complete renunciation |